Skip to Main content Skip to Navigation
Theses

Rôle dual de PPARγ dans les tumeurs de la vessie

Abstract : Bladder tumors are the fourth cancer in terms of frequency in men, in industrialized countries. Bladder cancers can be divided into two main subgroups: undifferentiated basal tumors and differentiated luminal tumors. The nuclear receptor PPARγ, which is highly expressed in the second subgroup, forms a heterodimer with its partner, the nuclear receptor RXRα, and plays a key role in normal urothelial differentiation. A protumorigenic role of PPARγ has been established in luminal bladder cancer, with an increased activity through PPARγ genomic amplification or activating mutations of its partner, RXRα. The first part of my project aimed to better characterize this protumorigenic effect. I first participated in the identification of recurrent activating mutations of PPARγ in the luminal subgroup, enhancing its protumorigenic role in those tumors. Then, I tried to identify the PPARγ/RXRα heterodimer target genes that drive its protumorigenic role. By analyzing transcriptomic data following down regulation of PPARγ and RXRα, as well as ChIP-sequencing data for each of them, I identified 30 candidate target genes. The implication of the candidate genes in tumor progression of luminal cancer carrying PPARγ/RXRα pathway alteration is in progress. As opposed to its protumorigenic role in luminal tumors, some results suggested that PPARγ could play a tumor suppressor role in the basal subgroup. The second part of my project explored this hypothesis. I characterized PPARγ deletions associated with the basal subgroup, which presents a global PPARγ downregulation. Moreover, some of the non-recurrent mutations identified in this subgroup are inactivating mutations, able to inhibit the transcriptomic activity of the PPARγ/RXRα heterodimer, by an enhanced affinity of the heterodimer for co-repressors. I also showed an antitumor effect of PPARγ in basal tumors: its expression in basal bladder cell lines after transfection with a plasmid coding for PPARγ was able to inhibit cell viability. This project highlighted the dual role of PPARγ in bladder tumors, with a protumorigenic effect in luminal tumors through amplifications and activating mutations, and a tumor suppressor effect in basal tumors through deletions and inactivating mutations.
Complete list of metadata

https://tel.archives-ouvertes.fr/tel-03188391
Contributor : Abes Star :  Contact
Submitted on : Friday, April 2, 2021 - 1:02:02 AM
Last modification on : Saturday, April 3, 2021 - 3:28:00 AM
Long-term archiving on: : Saturday, July 3, 2021 - 6:09:01 PM

File

68406_COUTOS-THEVENOT_2019_arc...
Version validated by the jury (STAR)

Identifiers

  • HAL Id : tel-03188391, version 1

Citation

Laure Coutos-Thévenot. Rôle dual de PPARγ dans les tumeurs de la vessie. Cancer. Université Paris Saclay (COmUE), 2019. Français. ⟨NNT : 2019SACLS141⟩. ⟨tel-03188391⟩

Share

Metrics

Record views

125

Files downloads

97